Does pravastatin affect circulating levels of soluble TNF receptor 2 in hypercholesterolemic patients?
- 28 February 2003
- journal article
- other
- Published by Elsevier in Atherosclerosis
- Vol. 166 (2), 413-414
- https://doi.org/10.1016/s0021-9150(02)00378-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Reduced levels of TNFα in hypercholesterolemic individuals after treatment with pravastatin for 8 weeksAtherosclerosis, 2001
- Pravastatin and the Development of Diabetes MellitusCirculation, 2001
- Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.Diabetes, 1998
- Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.Inflammation, 1998
- Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages.Journal of Clinical Investigation, 1997
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.The Journal of Experimental Medicine, 1992